restless legs and semaglutide For an adult with restless‑legs syndrome whose symptoms persist despite gabapentin, what pharmacologic options should be added to augment treatment? weight loss medication | Restless

Research parameters include resistance to acidic and enzymatic conditions, mucosal permeability, absorption kinetics, systemic biodistribution, and detection of intact peptide following enteral exposure

Please enter your username or email address, you will receive a link to create a new password via email

Any sudden changes in vision, symptoms of allergic reaction such as rash, swelling of the face or throat, or difficulty breathing require urgent medical assessment

Diabetes 69 , 313330 (2020)

Safety Advisory: A dose-dependent increase in the risk of atrial fibrillation has been consistently observed in major trials, especially at the 4 g/day dose, prompting regulatory safety advisories ( Guideline Recommendations: Based on this evidence, major guidelines now endorse the selective use of icosapent ethyl

American College of Cardiology/American Heart Association Task Force on Practice Guidelines, Obesity Expert Panel, 2013